Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

AbbVie | AustraliaAbbVie | Australia
VS
Hikma PharmaceuticalsHikma Pharmaceuticals
AbbVie | Australia

AbbVie | Australia

N/A

Last Update: 31/01/2026

View Profile
Between 750 and 799
https://www.abbvie.com.au
753/1000Fair

AbbVie is a research-driven biopharmaceutical company that delivers innovative therapies for complex conditions. We employ over 520 people, and our therapies currently benefit more than 200,000 Australians. By combining global scale with a biotech mindset, AbbVie devel...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:18
12-month incidents
0
Known data breaches
0
Attack type number
0
Hikma Pharmaceuticals

Hikma Pharmaceuticals

1 New Burlington Place, London, W1S 2HR, GB

Last Update: 03/04/2026

View Profile
Between 750 and 799
http://www.hikma.com
767/1000Fair

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospita...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:10,252
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
AbbVie | Australia

AbbVie | Australia

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Hikma Pharmaceuticals

Hikma Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for AbbVie | Australia in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Hikma Pharmaceuticals in 2026.

Incidents

Incident History - AbbVie | Australia (X = Date, Y = Severity)

AbbVie | Australia cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Hikma Pharmaceuticals (X = Date, Y = Severity)

Hikma Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
AbbVie | Australia

AbbVie | Australia

Incidents
No explicit notable incidents reported.
Hikma Pharmaceuticals

Hikma Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between AbbVie | Australia company and Hikma Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between AbbVie | Australia company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between AbbVie | Australia company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between AbbVie | Australia company and Hikma Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between AbbVie | Australia company and Hikma Pharmaceuticals company, which one has experienced at least one data breach ?
Between AbbVie | Australia company and Hikma Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between AbbVie | Australia company and Hikma Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between AbbVie | Australia company and Hikma Pharmaceuticals company, which one holds the most compliance certifications ?
Between AbbVie | Australia company and Hikma Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between AbbVie | Australia company and Hikma Pharmaceuticals company, which one has the most subsidiaries ?
Between AbbVie | Australia company and Hikma Pharmaceuticals company, which one has the largest number of employees ?
Between AbbVie | Australia and Hikma Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between AbbVie | Australia and Hikma Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - AbbVie | Australia or Hikma Pharmaceuticals ?
Which company is PCI DSS compliant - AbbVie | Australia or Hikma Pharmaceuticals ?
Between AbbVie | Australia and Hikma Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between AbbVie | Australia and Hikma Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-58523
SUMMARY

Improper access control in Microsoft Edge for Android allows an unauthorized attacker to bypass a security feature over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-14617
SUMMARY

A security vulnerability has been detected in NousResearch hermes-agent up to 2026.4.30. Affected is the function GatewayStreamConsumer._filter_and_accumulate of the file gateway/stream_consumer.py of the component Streaming Reasoning Tag Filter. The manipulation leads to improper handling of case sensitivity. The attack may be initiated remotely. The attack's complexity is rated as high. The exploitability is told to be difficult. The exploit has been disclosed publicly and may be used. The project decided to not implement a dedicated fix: "[T]he analysis and the fix are both sound. It just lands below the bar for the maintenance cost of a duplicated scrub path."

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 3.1)
CVSS2
Base Score: 2.1
Complexity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
CVSS3
Base Score: 3.1
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 1.3
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
1.6
CVE-2026-58597
SUMMARY

Insufficient ui warning of dangerous operations in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-58524
SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
CVE-2026-58522
SUMMARY

Relative path traversal in Microsoft Edge for Android allows an unauthorized attacker to disclose information locally.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N
IMPACT SCORE
4.2
EXPLOITABILITY
2.5